Jonathan M. Niloff

6.0k total citations · 1 hit paper
47 papers, 4.8k citations indexed

About

Jonathan M. Niloff is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan M. Niloff has authored 47 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan M. Niloff's work include Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Jonathan M. Niloff is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Jonathan M. Niloff collaborates with scholars based in United States and India. Jonathan M. Niloff's co-authors include Robert C. Bast, Robert C. Knapp, Thomas L. Klug, Elena Schaetzl, Ross S. Berkowitz, Eric L. Jenison, Thomas Leavitt, C. Thomas Griffiths, R. C. Knapp and Hillard M. Lazarus and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jonathan M. Niloff

47 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

1983 1.7k citations Robert C. Bast, Thomas L. Klug et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan M. Niloff United States	24	2.9k	1.2k	1.0k	994	930	47	4.8k
C. Thomas Griffiths United States	22	1.9k 0.7×	754 0.7×	578 0.6×	858 0.9×	484 0.5×	41	3.6k
Robert C. Knapp United States	45	4.5k 1.6×	2.0k 1.7×	1.6k 1.5×	1.5k 1.6×	1.5k 1.6×	135	8.2k
J. Taylor Wharton United States	48	2.7k 1.0×	1.2k 1.0×	2.9k 2.8×	2.5k 2.5×	1.2k 1.3×	166	7.5k
Harry J. Long United States	36	1.3k 0.4×	915 0.8×	2.2k 2.1×	1.1k 1.1×	467 0.5×	95	4.8k
Keiichi Fujiwara Japan	42	2.6k 0.9×	1.4k 1.2×	1.6k 1.6×	1.3k 1.3×	710 0.8×	364	6.7k
Alan Lamont United Kingdom	27	1.1k 0.4×	765 0.7×	377 0.4×	595 0.6×	822 0.9×	54	3.2k
Rodrigue Mortel United States	38	1.4k 0.5×	526 0.5×	1.9k 1.9×	939 0.9×	587 0.6×	122	4.6k
Federica Tomao Italy	38	1.1k 0.4×	1.2k 1.0×	607 0.6×	949 1.0×	642 0.7×	243	4.9k
Stephen A. Cannistra United States	30	2.0k 0.7×	2.0k 1.8×	475 0.5×	611 0.6×	718 0.8×	46	5.1k
Jason Konner United States	31	1.4k 0.5×	889 0.8×	536 0.5×	419 0.4×	910 1.0×	122	4.0k

Countries citing papers authored by Jonathan M. Niloff

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Niloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Niloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Niloff more than expected).

Fields of papers citing papers by Jonathan M. Niloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Niloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Niloff. The network helps show where Jonathan M. Niloff may publish in the future.

Co-authorship network of co-authors of Jonathan M. Niloff

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Niloff. A scholar is included among the top collaborators of Jonathan M. Niloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Niloff. Jonathan M. Niloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berkenblit, Anna, et al.. (2003). Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin. Gynecologic Oncology. 89(3). 486–493. 4 indexed citations

Nordstrom, Robert J., Louis Burke, Jonathan M. Niloff, & James F. Myrtle. (2001). Identification of cervical intraepithelial neoplasia (CIN) using UV‐excited fluorescence and diffuse‐reflectance tissue spectroscopy. Lasers in Surgery and Medicine. 29(2). 118–127. 90 indexed citations

Tung, Nadine, Ross S. Berkowitz, Ursula A. Matulonis, et al.. (2000). Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer. Gynecologic Oncology. 77(2). 271–277. 3 indexed citations

Burke, Louis, et al.. (1999). Identification of Squamous Intraepithelial Lesions. Journal of Lower Genital Tract Disease. 3(1). 49–49. 20 indexed citations

Burke, Louis, et al.. (1999). Identification of Squamous Intraepithelial Lesions: Fluorescence of Cervical Tissue During Colposcopy. Journal of Lower Genital Tract Disease. 3(3). 159–162. 23 indexed citations

Burke, Louis, et al.. (1998). Incidence and Predictors of Cervical Dysplasia in Patients With Minimally Abnormal Papanicolaou Smears. Obstetrics and Gynecology. 92(3). 356–359. 2 indexed citations

Abu‐Jawdeh, Graziella M., Timothy W. Jacobs, Jonathan M. Niloff, & S A Cannistra. (1996). Estrogen Receptor Expression Is a Common Feature of Ovarian Borderline Tumors. Gynecologic Oncology. 60(2). 301–307. 56 indexed citations

Cannistra, Stephen A. & Jonathan M. Niloff. (1996). Cancer of the Uterine Cervix. New England Journal of Medicine. 334(16). 1030–1037. 282 indexed citations

Ottensmeier, Christian H., Linda J. Swanson, Thomas Ströbel, et al.. (1996). Absence of constitutive EGF receptor activation in ovarian cancer cell lines. British Journal of Cancer. 74(3). 446–452. 13 indexed citations

10.

Cannistra, S A, Graziella M. Abu‐Jawdeh, Jonathan M. Niloff, et al.. (1995). CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.. Journal of Clinical Oncology. 13(8). 1912–1921. 81 indexed citations

11.

Ottensmeier, Christian H., et al.. (1995). Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer. Gynecologic Oncology. 58(2). 216–225. 111 indexed citations

12.

Flynn, Michael G. & Jonathan M. Niloff. (1995). Minilaparotomy for the ambulatory management of ovarian cysts. American Journal of Obstetrics and Gynecology. 173(6). 1727–1730. 13 indexed citations

13.

Tepler, I, S A Cannistra, Emil Frei, et al.. (1993). Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.. Journal of Clinical Oncology. 11(8). 1583–1591. 67 indexed citations

14.

Goodman, Howard M., Jonathan M. Niloff, William R. Welch, et al.. (1989). Adenocarcinoma of the uterine cervix: Prognostic factors and patterns of recurrence. Gynecologic Oncology. 33(2). 241–247. 38 indexed citations

15.

Loeffler, Jay S., et al.. (1988). Whole abdominal irradiation for tumors of the uterine corpus. Cancer. 61(7). 1332–1335. 11 indexed citations

16.

Niloff, Jonathan M., Robert C. Knapp, Philip T. Lavin, et al.. (1986). The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. American Journal of Obstetrics and Gynecology. 155(1). 56–60. 104 indexed citations

17.

Barbieri, Robert L., Jonathan M. Niloff, Robert C. Bast, et al.. (1986). Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertility and Sterility. 45(5). 630–634. 260 indexed citations

18.

Niloff, Jonathan M., Robert C. Knapp, & Robert C. Bast. (1985). Reply to Davies et al. American Journal of Obstetrics and Gynecology. 151(3). 420–420. 1 indexed citations

19.

Klug, Thomas L., Robert C. Bast, Jonathan M. Niloff, Robert C. Knapp, & Vincent R. Zurawski. (1984). Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.. PubMed. 44(3). 1048–53. 277 indexed citations

20.

Bast, Robert C., Thomas L. Klug, Elena Schaetzl, et al.. (1984). Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. American Journal of Obstetrics and Gynecology. 149(5). 553–559. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact